S. 3269 - Cannabidiol Research Expansion Act
- Sponsor:
- Dianne Feinstein
- Summary:
- A bill to require the Attorney General to make a determination as to whether cannabidiol should be a controlled substance and listed in a schedule under the Controlled Substances Act and to expand research on the potential medical benefits of cannabidiol and other marijuana components. (by CRS)
- Status:
- The bill has been referred to committee.
Cannabidiol Research Expansion Act
S. 3269 — 114th Congress (2015–2016)
- Summary
- A bill to require the Attorney General to make a determination as to whether cannabidiol should be a controlled substance and listed in a schedule under the Controlled Substances Act and to expand research on the potential medical benefits of cannabidiol and other marijuana components. (by CRS)
- Learn More
- At OpenCongress
- Title
- A bill to require the Attorney General to make a determination as to whether cannabidiol should be a controlled substance and listed in a schedule under the Controlled Substances Act and to expand research on the potential medical benefits of cannabidiol and other marijuana components.
- Other Titles
- Cannabidiol Research Expansion Act
- Cannabidiol Research Expansion Act
- Sponsor
- Dianne Feinstein
- Co-Sponsors
- Subjects
- Crime and law enforcement
- Alternative treatments
- Child health
- Drug therapy
- Drug trafficking and controlled substances
- Government studies and investigations
- Health personnel
- Higher education
- Licensing and registrations
- Medical research
- Neurological disorders
- Trade restrictions
- Related Bills
- Major Actions
Introduced 7/14/2016 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 7/14/2016 7/14/2016 Introduced in Senate 7/14/2016 Read twice and referred to the Committee on the Judiciary. Number Sponsor Date Offered Status
Total contributions given to Senators from interest groups that…
supported this bill
Contributions data source: OpenSecrets.org